Recently, a first comprehensive IHC-based study in patient samples has confirmed highly distinct characteristics of SCLC tumors expressing ASCL1 (SCLC-A) and/or NEUROD1 (SCLC-N) (86%) compared to SCLC lacking these markers (14%) [59]. The gene discussed is NEUROD1; the disease is small cell lung carcinoma.